Predicting breast cancer drug response using a multiple-layer cell line drug response network model.

Shujun HuangPingzhao HuTed M Lakowski

Published in: BMC cancer (2021)

The ML-CDN2 model was built to predict BC drug response using comprehensive information from both cell lines and drugs. Compared with existing methods, it has the potential to predict the drug response for BC patient-derived samples.

Keyphrases

adverse drug
emergency department
drug induced
risk assessment
climate change
human health